XTSX
OTC
Market cap33mUSD
, Last price
CAD
Name
Ocumetics Technology Corp
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
110.02%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-5m
L+77.80%
CFO
-3m
L+38.50%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ocumetics Technology Corp. is an innovation-driven enterprise specializing in the development and production of diverse optical lenses. One of its key innovations is the Bionic Lens, an expandable intraocular lens crafted to be implanted within the eye's natural lens compartment, offering a solution that eliminates the need for external vision correction. The company maintains its corporate headquarters in Calgary, Canada.
Key people
Dean Burns
President and Chief Executive Officer, Director · since 2023
Roger Jewett
Chief Financial Officer and Director · since 2018
Dayton Marks
Director · since 2022
R. Doyle Stulting
Chief Medical Officer and Director · since 2023
Garth Webb
Chief Scientific Officer, Chairman of the Board · since 2012
Michael Edwards
Independent Director · since 2025
J. Barton McRoberts
Independent Director · since 2023
Robert Quinn
Independent Director · since 2021
Headquarters & legal address
1250, 639 5th Avenue S.W.
Calgary, AB T2P 0M9
CA
Calgary, AB T2P 0M9
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑07 | 2020‑12 | 2020‑07 | 2019‑12 | 2018‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||